Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00102414
Status:
COMPLETED
Last Update Posted:
2006-11-14
First Post:
2005-01-29
Brief Title:
Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer
Sponsor:
AGO Study Group
Organization:
AGO Study Group
Organization Data
Organization:
AGO Study Group
Class:
OTHER
Study ID:
AGO-OVAR 25
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AGO Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None